These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29032374)

  • 21. Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases.
    Björnsson B; Sparrelid E; Hasselgren K; Gasslander T; Isaksson B; Sandström P
    Scand J Surg; 2016 Sep; 105(3):158-62. PubMed ID: 26929296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases.
    Joechle K; Moser C; Ruemmele P; Schmidt KM; Werner JM; Geissler EK; Schlitt HJ; Lang SA
    World J Surg Oncol; 2017 Mar; 15(1):57. PubMed ID: 28270160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center.
    Alvarez FA; Ardiles V; de Santibañes M; Pekolj J; de Santibañes E
    Ann Surg; 2015 Apr; 261(4):723-32. PubMed ID: 25493362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-Stage Hepatectomy and ALPPS for Advanced Bilateral Liver Metastases: a Tailored Approach Balancing Risk and Outcome.
    Baumgart J; Jungmann F; Bartsch F; Kloth M; Mittler J; Heinrich S; Lang H
    J Gastrointest Surg; 2019 Dec; 23(12):2391-2400. PubMed ID: 30820795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
    Rhaiem R; Duramé A; Primavesi F; Dorcaratto D; Syn N; Rodríguez ÁH; Dupré A; Piardi T; Fernández GB; Villaverde AP; Rodríguez Sanjuán JC; Santiago RF; Fernández-Moreno MC; Ferret G; Ben SL; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E; Kianmanesh R; Di Martino M
    Surgery; 2024 Jul; 176(1):124-133. PubMed ID: 38519408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Buettner S; Amini N; Pawlik TM
    J Surg Oncol; 2016 Sep; 114(3):361-7. PubMed ID: 27264476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.
    Shindoh J; Nishioka Y; Yoshioka R; Sugawara T; Sakamoto Y; Hasegawa K; Hashimoto M; Kokudo N
    Ann Surg Oncol; 2016 Jun; 23(6):1890-6. PubMed ID: 26786089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associating Liver Partition and Portal vein ligation for Staged hepatectomy after pre-operative chemotherapy.
    Vondran FWR; Oldhafer F; Ringe KI; Wirth TC; Kleine M; Jäger MD; Klempnauer J; Bektas H
    ANZ J Surg; 2018 Apr; 88(4):E324-E328. PubMed ID: 28419692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
    Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH
    J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALPPS versus two-stage hepatectomy for colorectal liver metastases--a comparative retrospective cohort study.
    Bednarsch J; Czigany Z; Sharmeen S; van der Kroft G; Strnad P; Ulmer TF; Isfort P; Bruners P; Lurje G; Neumann UP
    World J Surg Oncol; 2020 Jun; 18(1):140. PubMed ID: 32580729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure.
    Røsok BI; Björnsson B; Sparrelid E; Hasselgren K; Pomianowska E; Gasslander T; Bjørnbeth BA; Isaksson B; Sandström P
    Surgery; 2016 May; 159(5):1279-86. PubMed ID: 26606881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS.
    Chan ACY; Chok K; Dai JWC; Lo CM
    Surgery; 2017 Feb; 161(2):357-364. PubMed ID: 27596751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) procedure for colorectal liver metastasis.
    Hernandez-Alejandro R; Ruffolo LI; Alikhanov R; Björnsson B; Torres OJM; Serrablo A
    Int J Surg; 2020 Oct; 82S():103-108. PubMed ID: 32305531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT.
    Røsok BI; Høst-Brunsell T; Brudvik KW; Carling U; Dorenberg E; Björnsson B; Lothe RA; Bjørnbeth BA; Sandström P
    HPB (Oxford); 2019 Aug; 21(8):1017-1023. PubMed ID: 30765198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy is associated with better oncological outcomes after ALPPS for colorectal liver metastases.
    Alvarez FA; Ardiles V; Chara C; de Santibañes M; Sánchez Clariá R; Pekolj J; de Santibañes E
    Updates Surg; 2024 Jun; 76(3):855-868. PubMed ID: 38647857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
    Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
    Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.